Next-generation gene sequencing (NGS) technologies --in which millions of DNA molecules are simultaneously but individually analyzed-- theoretically provides researchers and clinicians the ability to ...
(San Diego, Calif.--September 7, 2024, 8:30 a.m. PCT) — Research presented today suggests an artificial intelligence tool called DeepGEM may provide an advancement in genomic testing that offers an ...
Comparative genomic landscape of patients with lung cancer with high-load versus low-load Epstein-Barr virus infection. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This ...
Against this backdrop, a team led by Professor Zhang Han and Associate Professor Chen Zhi from Shenzhen University in China , has demonstrated an innovative approach that combines DNA origami, CRISPR ...
Bryan Tieman is a Principal Scientist in the Diagnostics Division of Abbott Laboratories (IL, USA) and is a member of the Biologics Discovery Group where he creates binding agents and targets for the ...
Characterization of the microRNAome in a patient with acute myeloid leukemia. Background: The PIK3CA gene is mutated in ∼25% of breast cancer cases and has been proposed as a potential biomarker for ...
There is little doubt within the scientific community of the immense impact that next-generation sequencing (NGS) has had on translational research. Techniques like liquid biopsy have allowed ...
Johns Hopkins Medicine. "Hopkins-led research team takes gene mutation detection in blood to the next level." ScienceDaily. ScienceDaily, 4 May 2021. <www.sciencedaily.com / releases / 2021 / 05 / ...
The MarketWatch News Department was not involved in the creation of this content. Research presented today suggests an artificial intelligence tool called DeepGEM may provide an advancement in genomic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results